ABSTRACT Background: Butter is rich in saturated fat [saturated fatty acids (SFAs)] and can increase plasma low density lipoprotein (LDL) cholesterol, which is a major risk factor for cardiovascular disease. However, compared with other dairy foods, butter is low in milk fat globule membrane (MFGM) content, which encloses the fat. We hypothesized that different dairy foods may have distinct effects on plasma lipids because of a varying content of MFGM. Objective: We aimed to investigate whether the effects of milk fat on plasma lipids and cardiometabolic risk markers are modulated by the MFGM content. Design: The study was an 8-wk, single-blind, randomized, controlled isocaloric trial with 2 parallel groups including overweight men and women (n = 57 randomly assigned). For the intervention, subjects consumed 40 g milk fat/d as either whipping cream (MFGM diet) or butter oil (control diet). Intervention foods were matched for total fat, protein, carbohydrates, and calcium. Subjects were discouraged from consuming any other dairy products during the study. Plasma markers of cholesterol absorption and hepatic cholesterol metabolism were assessed together with global geneexpression analyses in peripheral blood mononuclear cells. Results: As expected, the control diet increased plasma lipids, whereas the MFGM diet did not [total cholesterol (6SD): +0.30 6 0.49 compared with 20.04 6 0.49 mmol/L, respectively (P = 0.024); LDL cholesterol: +0.36 6 0.50 compared with +0.04 6 0.36 mmol/L, respectively (P = 0.024); apolipoprotein B:apolipoprotein A-I ratio: +0.03 6 0.09 compared with 20.05 6 0.10 mmol/L, respectively (P = 0.007); and non-HDL cholesterol: +0.24 6 0.49 compared with 20.14 6 0.51 mmol/L, respectively (P = 0.013)]. HDL-cholesterol, triglyceride, sitosterol, lathosterol, campesterol, and proprotein convertase subtilisin/kexin type 9 plasma concentrations and fatty acid compositions did not differ between groups. Nineteen genes were differentially regulated between groups, and these genes were mostly correlated with lipid changes. Conclusions: In contrast to milk fat without MFGM, milk fat enclosed by MFGM does not impair the lipoprotein profile. The mechanism is not clear although suppressed gene expression by MFGM correlated inversely with plasma lipids. The food matrix should be considered when evaluating cardiovascular aspects of different dairy foods. This trial was registered at clinicaltrials.gov as NCT01767077.
INTRODUCTION
Elevated serum cholesterol is a major risk factor for cardiovascular disease (CVD) 7 and, thus, a key target for dietary intervention. Milk fat (e.g., butter) has long been recognized as having cholesterol-raising effects that are caused by the high content of long-chain SFAs, especially when compared with that of vegetable oils rich in unsaturated fatty acids (1, 2) . In Finland, population-based interventions aimed at reducing butter specifically resulted in major decreases in serum cholesterol concentrations and the incidence of CVD (3) . However, epidemiologic studies suggested that the association between milk fat intake and CVD is partly dependent on the type of dairy food consumed (4) (5) (6) . Notably, controlled studies showed that butter causes higher cholesterol concentrations than does cheese even with a similar intake of milk fat (7) (8) (9) (10) . The consumption of fermented cheeses has been proposed to explain these differences; in addition, the food matrix may possibly modulate the hypercholesterolemic effects of saturated fat. However, comparisons between cheese and butter are difficult to interpret because of differences in protein and micronutrient contents, and cheese is also a fermented product, which may modify the effect (11, 12) . Several decades ago, it was hypothesized that the differential effects of various dairy foods on plasma lipids might be caused by the presence of milk fat globule membrane (MFGM) (13) . MFGM is a tri-layered membrane rich in bioactive phospholipids (e.g., sphingolipids) and proteins enclosing the milk fat (14) , which have putative favorable metabolic effects (15) . Bovine MFGM consists of w70% lipids and w20% proteins (16) . Animal studies showed that MFGM and sphingolipids could lower plasma cholesterol partly by modulating hepatic gene expression (17) (18) (19) (20) (21) (22) . The content and physical structure of MFGM are differentially preserved in dairy products. Compared with other dairy products, butter has a relatively low MFGM content (as assessed by phospholipids) because of the churning process. In this process, most of the MFGM is transferred to the butter-milk fraction (14) . Cream contains twice as much MFGM as butter on a per gram of fat basis (14) . Recent trials that used MFGM-enriched powder showed conflicting results; 2 studies showed no effect of MFGM on fasting (23) or postprandial (24) lipid concentrations, whereas another study showed significant reductions in both fasting total cholesterol and LDL cholesterol (25) . Most importantly, studies that use MFGM-enriched powder can test only the effects of MFGM components because the physical and chemical properties, physical state, and structure of individual components of MFGM may change during processing. To the best of our knowledge, no trial has compared the effects of physically intact MFGM by using non-fermented food items (e.g., butter or butter oil compared with cream) on lipid profiles.
We hypothesized that MFGM-enclosed milk fat (e.g., cream) would have less of a cholesterol-raising effect than would milk fat devoid of MFGM (e.g., butter oil). With the use of a randomized controlled study design, we aimed to investigate whether the effect of milk fat on plasma lipids is modulated by the presence of intact MFGM. In addition, we examined the influence of 2 diets that differed mainly in MFGM on global gene expression and markers of cholesterol absorption and synthesis to study potential mechanisms.
METHODS

Subjects
Healthy, overweight men and women were recruited by local advertising. Inclusion criteria were age from 20 to 70 y, BMI (in kg/m 2 ) from 25 to 37, and LDL-cholesterol concentrations from 2.0 to 4.5 mmol/L. Exclusion criteria were as follows: CVD, diabetes, or liver disease; the use of lipid-lowering drugs, omega-3 supplements, or extreme diets; an intolerance to gluten or milk protein; pregnancy or lactation; regular heavy exercise (.3 h/wk); or abnormal clinical chemistry.
Study design
The MFGM study was an 8-wk, single-blind randomized trial with 2 parallel groups in free-living subjects. The study was carried out from January 2013 through June 2013 at the Uppsala University Hospital, Uppsala, Sweden (clinicaltrials.gov; NCT01767077). The study was isocaloric (weight stability defined as 61.5 kg), and all subjects were instructed to maintain their usual diets (apart from the intervention), physical activity levels, and alcohol habits throughout the study. Before all clinic visits, subjects were instructed to fast for 12 h and abstain from physical exercise or alcohol intake for 48 h. All subjects also visited the clinic weekly for weight measurement, food distribution, and general support. At screening, subjects completed a form regarding habitual intake of dairy products. At random assignment, subjects were stratified by sex, age (greater than or less than the median age), LDL cholesterol (greater than or less than the median value), and habitual intake of dairy products (low or high).
Dietary intervention and food items
Apart from achieving a difference between the 2 intervention products regarding intact MFGM, we aimed to match intervention products for energy intake, total fat content (including saturated fat), carbohydrates, protein, and calcium. Subjects in the MFGM group received 1 dL whipping cream (40% fat)/d, 1 dL fat-free milk (0.1% fat)/d, and 1 scone/d (baked with wheat flour, water, sodium chloride, and baking powder). The whipping cream was pasteurized (4 s at 958C) but not homogenized. Subjects were not allowed to heat, mix, or whip the cream. We chose whipping cream because of its high content of phospholipids and because the MFGM contained in the whipping cream was shown to have a relatively intact structure (Figure 1) . Subjects in the control group received 1 dL fat-free milk (0.1% fat)/d and 1 scone/d [baked with wheat FIGURE 1 Confocal laser scanning microscopy micrograph of milk fat globules from whipping cream (40% fat) stained with Alexa WGA 488 (Invitrogen) and Nile red (Sigma-Aldrich) fluorescent dyes; fat appears red, and milk fat globule membrane appears green. Images were captured at magnification 32.58 with an objective lens 360. Scale bar = 10 mm.
flour, water, butter oil (98.7% fat), sodium chloride, baking powder, and milk protein isolate (Promilk 852 A; Ingredia Essential)]. The milk protein isolate was used to balance the 2 diets with regard to protein and calcium. Subjects in both groups were allowed to use the daily allotted fat-free milk as they wished (e.g., in coffee) and could choose the time for consumption of the intervention foods each day. The butter oil was produced by using a traditional butter-oil process at Arla Foods. We chose butter oil as the control fat because of its near-complete deficiency of phospholipids and MFGM (Figure 2 ). Scones were baked under standardized conditions in a metabolic kitchen. Table 1 provides a nutritional comparison of intervention foods. Both fat-free milk and whipping cream were delivered to subjects in neutral packages, and subjects were blinded as to which dietary products they received in the study. Subjects were not allowed to consume any other dairy products (or products that contained considerable amounts of dairy) or margarines during the whole study.
Dietary assessment
Dietary intake was assessed by using 4-d weighed-food records and processed with the Dietitian Net Pro (version 1.0, food database updated 3 January 2014; National Food Agency) dietary assessment software (http://www.kostdata.se). Subjects also completed daily checklists to report intakes of intervention foods and any intake of other dairy products. Checklists were handed in at weekly clinic visits.
Anthropometric measures
Height was measured without shoes by using a wall-mounted stadiometer to the nearest 0.5 cm. Body weight was measured by using a digital scale to the nearest 0.1 kg. The sagittal abdominal diameter (abdominal height) was measured at the level of the iliac crest after a normal expiration to the nearest 0.1 cm in a supine position with legs bent on a firm examination table without clothes in the measurement area.
Biochemical analyses
Total cholesterol, LDL cholesterol (measured directly), HDL cholesterol, glucose, insulin, apolipoprotein B, apolipoprotein A-I, C-reactive protein, and triglycerides were measured by using standardized methods at Uppsala University Hospital.
Cholesterol metabolism
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in plasma was measured by using human PCSK9 ELISA kits (catalogue no. Circulex CY-8079; CycLex). Unesterified lathosterol (reflecting whole-body cholesterol synthesis) was determined by using isotope-dilution mass spectrometry (26) . Lathosterol concentrations were corrected for total cholesterol (27) . Plant sterols sitosterol and campesterol (markers of absorption of dietary cholesterol) were determined by using gas chromatography-mass spectrometry as described previously (26) . Serum plant sterol concentrations were normalized for total plasma cholesterol. VLDL fractions were obtained by fast-performance liquid chromatography by using kits from Roche Diagnostics Gmbh and calculated from the AUC (28).
Fatty acid composition
The fatty acid composition, including the specific milk fat markers pentadecanoic acid (15:0) and heptadecanoic acid (17:0), was measured in plasma cholesterol esters and plasma phospholipids by using gas chromatography as previously described (29) . Desaturase-activity indexes were estimated by product-to-precursor ratios in plasma cholesterol esters. Stearoyl-CoA desaturase-1 activity was estimated as the palmitoleic acid (16:1) n-7:palmitic acid (16:0) ratio, d5-desaturase was estimated as the arachidonic acid (20:4n-6):dihomogammalinolenic acid (20:3n-6) ratio, and d6-desaturase was estimated as the gammalinolenic acid (18:3n-6):linoleic acid (18:2n-6) ratio.
Gene expression in peripheral blood mononuclear cells
Blood was collected in cell preparation tubes (no. 362782; Becton Dickinson ). Samples were centrifuged at room temperature for 20 min at 1800 3 g. The cell layer was collected, mixed with phosphate-buffered saline (no. 14190-094; Invitrogen) and centrifuged at room temperature for 15 min at 300 3 g. The FIGURE 2 Confocal laser scanning microscopy micrograph of milk fat globules in an emulsion made from butter oil, purified water, and sodium dodecyl sulfate (15% fat) stained with Nile red (Sigma-Aldrich) and Alexa WGA 488 (Invitrogen) fluorescent dyes; fat appears as red, and milk fat globule membrane appears as green. Images were captured at magnification 32.58 with an objective lens 360. Scale bar = 10 mm. supernatant was removed, and the pellet was mixed with RLT buffer (RNeasy Mini Kit, no. 74106; Qiagen) and b-mercaptoethanol (M-3148; Sigma) and stored at 2708C until RNA extraction. Total RNA was extracted by using the RNeasy Mini Kit according to the manufacturer's instructions. RNA concentration and purity were measured by using a Nanodrop ND-1000 Spectrophotometer (Thermo Fisher Scientific). RNA integrity was checked by using a bioanalyzer device (Agilent 2100 Bioanalyzer; Agilent Technologies). We randomly selected a subgroup of 15 women from the MFGM group and 15 women from the control group for transcriptome analyses. From total RNA, we prepared and hybridized biotinylated complementary RNA to Human Gene 1.1 ST Arrays (Affymetrix Inc.) and washed, stained, and scanned the slides by using standardized protocols. Microarray hybridizations were done at the local Bioinformatics and Expression Analysis core facility (http://www.bea.ki.se). Gene 1.1 ST Arrays determine the expression of 28,869 transcripts. Subsequent data analyses were performed by using the Affymetrix Expression Console (version 1.1; Affymetrix Inc.). One sample in the control group did not pass quality control and was, therefore, excluded from the subsequent analysis. To allow for comparisons of transcripts between samples, all samples were subjected to an allprobe-set scaling-to-target signal of 100. We excluded probe sets that targeted uncharacterized transcripts and noncoding RNA, which left 23,752 probe sets. We filtered for transcripts with a large variation in expression between samples (i.e., the ratio of SD to average expression $0.11 and average signal on the array $20), which left 13,017 probe sets for phenotypic analysis. The microarray data were submitted to the Gene Expression Omnibus in a Minimum information about a microarray experiment-compliant format (GSE60148).
Confocal laser scanning microscopy of labeled MFGM
To observe fat globules and MFGM, the cream sample was stained with Nile red (Sigma-Aldrich) and a lectin [wheat germ agglutinin (WGA), Alexa Fluor conjugate (WGA 488); Invitrogen)]. The fat-specific stain Nile red stains only the fat core of the globules and, therefore, gives no information about the MFGM. A previous study (30) showed that the lectin WGA binds to and fluorescently labels the MFGM in bovine milk. A 40-mL aliquot of Nile red (50 g/L acetone solution) and 20 mL of WGA 488 (40 g/L water solution) stains were transferred to a slide (0.7 mm) (ProSciTech) and allowed to dry. The sample (80 mL) was placed on top of the dried stain spot and immediately analyzed by using confocal laser scanning microscopy. The microstructure of the cream was observed by using an inverted confocal scanning laser microscope (Modular Confocal Microscope System Nikon C2/Nikon Eclipse TE 2000-U; Nikon Corp.) powered by Diode Pumped Solid State and helium/neon lasers. The sample was viewed by using an oil immersion 360 lens (1.4 numerical aperture), and the pinhole diameter was 1.2 Airy unit. Nile red was excited at a wavelength of 543 nm (emission was detected between 553 and 618 nm) and WGA 488 at 488 nm (emission was detected between 499 and 529 nm). In the images obtained, the Nile red-stained fat appeared red, and the WGA 488-stained MFGM appeared green. In contrast, the aqueous phase appeared black. Nikon confocal software (NIS-Elements Advanced Research; Nikon Corp.) was used to acquire digital images of 512 3 512 pixels in size (Figure 1 ).
Emulsion preparation of butter oil
Dissolved sodium dodecyl sulfate (VWR International bvba) in Milli-Q water (Millipore Corp.) at 4 mmol/L (0.5 3 critical micellar concentration) and butter oil was heated to 558C. At 558C, 30 g butter oil was added to 170 g sodium dodecyl sulfate solution during pre-emulsification with a rotor-stator type mixer at 24,000 3 g (DIAX 900; Heidolph) and emulsified for 300 s. The pre-emulsified butter oil emulsion was homogenized in a laboratory homogenizer (Panda Plus 2000; GEA Niro Soavi) at 10 bar first stage and 558C for 10 passes. After emulsification, resulting emulsions were rapidly cooled to 48C. Images were obtained as previously described (Figure 2 ).
Ethical consideration
The study was conducted in accordance with the Declaration of Helsinki. All subjects gave written informed consent before study inclusion, and the study was approved by the regional ethical review board in Uppsala.
Statistics
The difference in plasma LDL cholesterol between groups was the primary outcome. The power calculation indicated that 23 subjects/group were required (80% power; 5% type I error) to detect a difference (6SD) of 0.3 6 0.35 mmol/L in plasma LDLcholesterol concentration. Differences between groups were analyzed on a per-protocol basis by using Student's t test. Nonnormally distributed variables were log transformed or analyzed nonparametrically by using Wilcoxon's test if normality was not seen by using the Shapiro-Wilk test. Data are given as means (6SDs) or medians (IQRs). P , 0.05 was considered statistically significant. In addition to completers analyses, intention-to-treat (ITT) analyses were performed by using the last observation carried forward method. JMP version 10.0.0 software (SAS Institute) was used for data analyses.
Absolute differences in gene expression were calculated for each gene in each subject by comparing outcomes before and after the intervention. These absolute differences in gene expression were compared between intervention groups by using Student's t test and Significance Analysis of Microarrays software (SAM) version 3.0 (http://statweb.stanford.edu/~tibs/SAM/).
RESULTS
Five of the randomly assigned subjects dropped out of the study before the intervention started ( Figure 3 ). Two subjects (1 man and 1 woman) in the MFGM-diet group and 4 subjects (1 man and 3 women) in the control-diet group dropped out of the study during the intervention, which left 26 completers (18 women) and 20 completers (16 women) for MFGM and control diets, respectively. All baseline data presented are for completers. The median age was 58.5 y (IQR: 49.3-65.3 y) and 60.5 y (IQR: 49.3-65) in MFGM and control diet groups, respectively. The study population was overweight but otherwise healthy ( Table 2) .
Anthropometric measures
Anthropometric measures were virtually unchanged in both groups during the intervention ( Table 2 ). The change in body weight was ,1 kg in both groups [+0.17 6 1.1 kg (P = 0.44) in the MFGM-diet group and 20.64 6 1.4 kg (P = 0.06) in the control-diet group. The difference in changes between groups was significant (P = 0.043); however, significance was not maintained in the ITT analysis (P = 0.18). Changes in sagittal abdominal diameter did not differ between diets (P = 0.72; Table 2 ).
Dietary intake and compliance
On the basis of daily checklists and weekly dialogues, compliance in both groups was very good regarding both adhering to assigned intervention foods and abstaining from other dairy foods. Dietary intakes at baseline and changes during intervention are presented in Table 3 . In accordance with unchanged body weights of participants, total energy intake remained unchanged during the intervention. However, a small redistribution of energy intake from carbohydrates and fat occurred (Table 3) .
Plasma lipids and cholesterol homeostasis
Changes in LDL cholesterol and total cholesterol were significantly different between groups and favored the MFGM diet (Table 2 ) despite the modest decrease in weight in the control group. However, this weight change was NS between groups in ITT analyses as previously reported. Changes in non-HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratio were also significantly different between groups and favored the MFGM diet. All changes remained significant in the ITT analysis (P = 0.034 for LDL cholesterol, P = 0.03 for total cholesterol, P = 0.014 for non-HDL cholesterol, and P = 0.006 for the apolipoprotein B:apolipoprotein A-I ratio). Changes in HDL cholesterol, the LDL:HDL ratio, the total cholesterol:HDL ratio triglycerides, and apolipoprotein A-I did not differ between groups. Apolipoprotein B showed a tendency to differ between groups (P = 0.054), but significance was not reached. Changes in VLDL and PCSK9 did not differ between groups. No between-group differences were seen for changes in sitosterol, lathosterol, campesterol, and C-reactive protein (Table 2) .
Glucose homeostasis
Changes in fasting plasma glucose, insulin, and the HOMA-IR were not significantly different between groups (Table 2) .
Fatty acid composition and desaturases
In line with the study design, there were no significant differences between groups in the milk fat biomarkers 15:0 or 17:0 or in any other SFAs, PUFAs, or MUFAs. Similarly, estimated desaturase activity indexes in plasma cholesterol esters and plasma phospholipids remained unchanged in both diets during the intervention without any differences between diets ( Table 4) .
Gene expression in blood cells
We analyzed peripheral blood mononuclear cell (PBMC) gene expression in 15 randomly selected women from the MFGM group and 14 randomly selected women from the control group. Changes in gene expression between groups were significant (false discovery rate: 23%) for 19 genes ( Table 5 ). The function of most of these genes is poorly described. However, some of these genes have been implicated in the regulation of cell cycle and apoptosis (i.e., MDM2, TAF1D, UCP15, and APIP) and others in the ubiquitin regulation of intracellular protein degradation and endoplasmatic reticulum stress (UBE2E2, USP15, and USP45) (http://www.omim.org).The expression of all 19 genes were reduced in the MFGM group and increased in the control group. Changes in most of these genes correlated with changes in one or several of the differentially regulated plasma lipids ( Table 6 ).
DISCUSSION
In this single-blinded randomized controlled trial, we showed that milk fat enclosed by MFGM does not elevate plasma cholesterol, whereas the control milk fat impaired lipoprotein profiles in healthy humans. Although we could not completely rule out other nonmatrix components as an explanation for these differences, these results support the hypothesis that the presence of MFGM in dairy products may counteract the hypercholesterolemic effects of saturated fat.
The LDL-cholesterol-raising effect of butter is well known, and limiting the use of butter has led to major reductions of both serum cholesterol and CVD (3). As expected, the butter oil in the control diet caused a marked impairment of the lipoprotein profile not only by raising LDL cholesterol by 13% but also by increasing related CVD risk factors, including non-HDL cholesterol and the apolipoprotein B:apolipoprotein A-I ratio (31, 32) , compared with the MFGM diet. A cholesterol-raising effect of butter oil compared with whipping cream (including MFGM) is in keeping with previous controlled studies that compared butter and cheese (7-10) although, apart from being high in MFGM, the latter is fermented.
The mechanisms behind the potential effects of MFGM on plasma lipids are unclear but may involve reduced cholesterol absorption or phospholipid-induced alterations in hepatic gene expression. Animals fed high-fat diets supplemented with sphingolipids or a mixture of milk phospholipids show reduced intestinal cholesterol absorption, increased fecal lipid and cholesterol outputs, and reduced liver triglycerides, serum lipids, and blood glucose, all of which are associated with altered hepatic expression of genes in cholesterol metabolism and fatty acid synthesis (18) (19) (20) (21) (22) 33) . Some of these effects have also been associated with hepatic accumulation of phospholipids (33) . Besides the effects on hepatic gene expression, milk phospholipids also seem to effect the partitioning of lipids in classes both within and between organs (17) . Although data from the current study did not show a differential effect on plasma cholesterol mediated by differences in cholesterol synthesis or absorption, as assessed by the surrogate markers lathosterol, sitosterol, and campesterol, this possibility cannot be excluded until more-direct measurements in humans have been performed. The microarray analyses implied that the underlying mechanism may at least partly involve phospholipid-induced alterations in PBMC gene expression. All differentially expressed genes between groups were downregulated by the MFGM diet compared with the control diet. Furthermore, changes in gene expression strongly correlated with changes in circulating cholesterol concentrations, although none of the differentially regulated genes is known to us to regulate cholesterol metabolism as do, e.g., HMG-CoA, PCSK9, SREBP1c, CYP7A1, and MTP. Although previously suggested (34), PBMCs do not necessarily reflect hepatic gene expression.
We did not observe any significant differences between groups in the HOMA-IR, which did not support a role for MFGM in the modulation of insulin sensitivity. In a previous observational study, a positive association between plasma phospholipids (indicative of full-fat dairy intake) and insulin sensitivity was shown (35) . But it is unclear if such associations are caused by the full-fat dairy products themselves or other lifestyle factors. However, note that the current study did not measure insulin sensitivity directly.
Data from observational studies on butter and cream intake are few, and those available showed inconsistent associations with regard to CVD risk (4, 5, (36) (37) (38) (39) . In a large review of prospective cohort studies, it was shown that dairy foods overall were not associated with CVD, although the authors suggested that such a result may have been due to intakes of different dairy foods in the studies and, thus, probably a varying MFGM content (40) . There may also be sex differences; women had increased mortality and CVD risk with high intake of butter (but not with fermented full-fat milk) in a large Dutch cohort. This association was not seen in men (4) . Observational studies are unlikely to be able to differentiate between high-fat dairy foods and CVD risk because most individuals consume a mixture of dairy foods rather than consuming, for example, either butter or cream as the only sources of milk fat.
The current study had several strengths. Subjects were blinded to the study intervention and unaware of the particular products tested. With the assessment of habitual dairy intake at screening, we were able to stratify the groups to avoid imbalances between groups after random assignment. We used (nonfermented) food items instead of powders, which made the results directly applicable to common foods. The combination of daily checklists and weekly meetings resulted in a high rate of adherence both regarding the intake of the intervention food items and the avoidance of other dairy products. We also measured the fatty acid composition in plasma phospholipids and cholesterol esters, which indicated that no major changes in dietary fat composition occurred during the study. Last, we showed that MFGM had a relatively intact physical structure in the test product. This study also had limitations. Subjects were not allowed to heat, mix, or whip the cream; the effects may have been somewhat different if we would have used, e.g., a heat-treated cream. We used butter oil instead of butter as an attempt to eliminate "noise" in the MFGM content between diets; as a result, the effects reported in the current study may not necessarily be directly transferable to butter consumption. However, the LDL cholesterol-raising effect of butter oil is well in accord with that observed with butter (7, 9, 10) , and thus, the current results are likely transferable to those of butter. Notably, in commonly used high-fat dairy foods, butter has the lowest MFGM content. Another limitation is that the 2 fat sources compared had different physical states (liquid compared with solid), which possibly affected the results (41). Although we do not know how wellpreserved MFGM was in the whipping cream, our confocal laser scanning microscopy analyses indicated that it was relatively intact ( Figure 1) . Finally, the sample size of the current study was relatively small, and the findings need to be confirmed in larger clinical trials.
The results from our current study are in accord with previous animal studies that showed fewer adverse effects on plasma lipids by MFGM or its components (17) (18) (19) (20) (21) (22) than with other milk fats. Note that the current differences between the 2 milkfat diets in regard to lipoprotein response occurred despite high intakes of SFA. Because the fatty acid profile, including SFA, is similar between dairy foods (42), the cholesterol-raising effect of SFA in butter oil versus cream may be partly due to a lack of intact MFGM. However, the mechanisms are unclear, and the roles of physical structure and single components need additional study.
The plasma fatty acid composition did not change during the intervention regarding the milk fat biomarkers 15:0 or 17:0 or any PUFA, which all are considered good dietary biomarkers. This result implies that the milk fat dose used (40 g/d) corresponded to the habitual intake of milk fat in these subjects. The result also implies that subjects did not change their PUFA intake, which is known to lower plasma lipids. The overall dairy consumption in Sweden is high, and the average intake of dairy fat is w30 g/d. Notably, subjects in the current study generally consumed more dairy products than the population average, and accordingly, 40 g dairy fat/d seems a reasonable estimate of their intake. Results from food records indicated that intake of SFA increased in the MFGM group during the intervention, although this should be interpreted with caution because selfreported dietary intake may be less reliable than objectively measured biomarkers.
In conclusion, milk fat enclosed by MFGM does not raise plasma cholesterol in overweight but otherwise healthy adults. The MFGM component is potentially responsible for preventing the marked increase in plasma lipids observed in the control diet. These results highlight the importance of the food matrix, in addition to fermentation, and suggest that the effects of single components in dairy foods (e.g., saturated fat) do not necessarily correspond to the effects of all dairy foods that contain these components. The current results may also explain some of the inconsistent associations between dairy consumption (e.g., butter compared with cream or cheese) and CVD risk previously reported in cohort studies (40) .
